TAAR1 and neoplasm: The potent TAAR1 agonist amphetamine has been linked to cancer pathology since at least the 1990s, when daily amphetamine injections were found to increase tumor incidence, growth and metastases in virally-induced cancers on rats (Freire-Garabal et al., 1992, 1998).